Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Invasive Strategy After Fibrinolysis vs Standard Management in STEMI Patients: Results From an Individual Patient Data Meta-analysis (OTTER Meta-analysis) OTTER: Optimal Timing for Post-Thrombolysis Elective Revascularization

NCT01014182 is registered in ClinicalTrials.gov with Royal Brompton & Harefield NHS Foundation Trust as lead sponsor.

NCT NCT01014182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01014182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Invasive Strategy After Fibrinolysis vs Standard Management in STEMI Patients: Results From an Individual Patient Data Meta-analysis (OTTER Meta-analysis) OTTER: Optimal Timing for Post-Thrombolysis Elective Revascularization
Lead sponsor
Royal Brompton & Harefield NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2009
Completion date
December 31, 2009
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial infarction